Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual.

@article{McGregor2008SymptomsAS,
  title={Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual.},
  author={Catherine Elizabeth McGregor and Manit Srisurapanont and Amanda Christine Mitchell and Wendy A Wickes and Jennifer Marie White},
  journal={Journal of substance abuse treatment},
  year={2008},
  volume={35 3},
  pages={
          334-42
        }
}
The safety and tolerability of modafinil (400 mg/day, n = 14) and mirtazapine (60 mg/day, n = 13) in inpatient methamphetamine withdrawal treatment were compared to a historical comparison group receiving treatment as usual (pericyazine, 2.5-10 mg/day, n = 22). Modafinil and mirtazapine were well tolerated, producing minimal positive subjective effects and no discontinuation effects in this open-label study. Side effects were mild and transient. Aches and pains were most commonly reported by… CONTINUE READING
BETA

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 24 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 31 REFERENCES

A comparison of aripiprazole, methylphenidate

  • H Vorma
  • 2007

Similar Papers

Loading similar papers…